THE THERAPEUTIC AND DIAGNOSTIC MANAGEMENT TACTICS FOR PREGNANT WOMEN WITH ARTERIAL HYPERTENSION IN RUSSIA: TREATMENT POLICY (RESULTS OF THE DIALOG II MULTICENTER EPIDEMIOLOGICAL STUDY)


Дәйексөз келтіру

Толық мәтін

Аннотация

The DIALOG II was conducted to examine therapeutic management tactic in pregnant women with arterial hypertension and the pharmacoepidemiology of antihypertensive agents used in pregnant women in Russia versus the results of the 2005- 2006 DIALOG I study. A total of2033 physicians from 27 cities and town of Russia were interviewed by a questionnaire. The study has indicated that in real clinical practice there are no generally accepted criteria for the start of antihypertensive therapy; 7.4% of the physicians continue to prescribe ACE inhibitors and other unrecommended agents to pregnant women; for the treatment of arterial hypertension, almost 80% of the physicians use drugs that are not properly antihypertensive.

Авторлар туралы

R OGANOV

O TKAChEVA

O Tkacheva

Әдебиет тізімі

  1. Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России. - М., 2007.
  2. Многоцентровое эпидемиологическое исследование «Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России «ДИАЛОГ» //Артериальная гипертен- зия. - 2008. - Т. 14, № 1. - С. 27-39.
  3. Рабочая группа по лечению артериальной гипертонии Европейского общества гипертонии (ESH) и Европейского общества кардиологов (ESC). Рекомендации 2007 г. по лечению артериальной гипертонии // Рацион. Фармакотер. в кардиол. - 2008. - № 1-2. - С. 51-53.
  4. Abalos E., Duley L., Steyn D. et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy // Cochrane Database Syst. Rev. - 2007. - № 1. - CD002252.
  5. Bortolus R., Ricci E., Chatenoud L. et al. Nifedipine administered in pregnancy: effect on the development of children at 18 months // Br. J. Obstet. Gynaecol. - 2000. - 107. - Р. 792-794.
  6. Buttar H.S. An overview of the influence of ACE inhibitors on fetal placental circulation and perinatal development // Mol. Cell. Biol. - 1997. - Vol.176. - P. 61-71.
  7. Cockburn J., Moar V.A., Ounsted M. et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children // Lancet. - 1982. - Vol. 1. - P. 647-649.
  8. Cooper W.O., Hernandez-Diaz S., Arbogast P.G. et al. Major congenital malformations after first-trimester exposure to ACE inhibitors // N. Engl. J. Med. - 2006. - Vol. 354. - P. 2443-2451.
  9. Dadelszen P., Ornstein M.P., Bull S.B. et al. Fall in mean arterial pres // Lancet. - 2000. - Vol. 355 - P. 87-92.
  10. Dadelszen P., Magee L.A. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis // J. Obstet. Gynaecol. Can. - 2002. - Vol. 24, № 12. - P. 941-945.
  11. Diagnostik und Therapie hypertensiver schwanger- schaftserkrankungen Deutsche Gesellschaft fur Gynakologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Schwangerschaftshochdruck // Gestose. - 2008. - P. 24.
  12. Expert consensus document on management of cardiovascular diseases during pregnancy // Eur. Heart J. - 2003. - Vol. 24, № 8. - P. 761-781.
  13. Groves T.D., Corenblum B. Spironolactone therapy during human pregnancy //Am. J. Obstet. Gynecol. - 1995. - Vol. 172. - P. 1655-1656.
  14. Hypertension Guideline Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy// J. Obstet. Gynaecol. Can. - 2008. Vol. 30, № 3. - S1-S48.
  15. Lambot MA, Vermeylen D, Noel JC. Angiotensin- II-receptor inhibitors in pregnancy // Lancet. - 2001. - Vol. 3571. - P. 1619-1620.
  16. Lowe S.A., Brown M..A, Dekker G. et al. Guidelines for the management of hypertensive disorders of pregnancy // Society of Obstetric Medicine of Australia and New Zealand (SOMANZ). - 2008, P. 31.
  17. Magee L.A. Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy // Cochrane Database Syst. Rev. - 2000. - CD002863.
  18. Magee L.A., .Schick B., Donnenfeld A.E. et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study //Am. J. Obstet. Gynecol. - 1996. - Vol. 174. - P. 823-828.
  19. Magee L.A., von Dadelszen P., Chan S. et al. The CHIPS Pilot Trial (Control of Hypertension In Pregnancy Study) // J. Obstet. Gynaecol. Can. - 2006. - Vol. 28. - P.416.
  20. Martin J.N.Jr., Thigpen B.D., Moore R.C. et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure // Obstet. Gynecol. - 2005. - Vol. 105. - P. 246-254.
  21. Paran E., Holzberg G., Mazor M. et al. Beta-adrenergic blocking agents in the treatment of pregnancy- induced hypertension // Int. J. Clin. Pharmacol. Ther. - 1995. - Vol. 33. - P. 119-123.
  22. Report ofthe National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy //Am. J. Obstet. Gynecol. - 2000. - Vol. 183, № 1. - Р. S1-S22.
  23. Saji H., Yamanaka M., Hagiwara A. et al. Losartan and fetal toxic effects //Lancet. - 2001. - Vol. 357. - P. 363-367.
  24. Schefer Ch., Peters W.J., Miller R.K. Drugs during pregnancy and lactation. - New York: Academic press, 2007.
  25. Tiina P., August Ph. Update on the use of antihypertensive drugs in pregnancy // Hypertension. - 2008. - Vol. 51. - P. 960-969.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2010

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>